Join to view full profile
1500 Duarte RdSuite 200Duarte, CA 91010
Phone+1 626-359-8111
Fax+1 626-930-5362
Dr. Waisman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cedars-Sinai Medical CenterFellowship, Hematology and Medical Oncology, 1975 - 1978- Cedars-Sinai Medical CenterResidency, Internal Medicine, 1973 - 1975
- Cedars-Sinai Medical CenterInternship, Internal Medicine, 1972 - 1973
Medical College of WisconsinClass of 1972
Certifications & Licensure
CA State Medical License 1973 - 2026
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Sunrise Acute Care, Allscripts, 2014-2017
- CMS Meaningful Use Stage 1 Certification Sunrise Patient Portal and Sunrise Ambulatory Care EHR, Allscripts, 2014-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR (Complete), Allscripts, 2014-2017
Clinical Trials
- Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer Start of enrollment: 2017 Mar 31
Roles: Principal Investigator, Contact
- Pembrolizumab, Endocrine Therapy, and Palbociclib in Treating Postmenopausal Patients With Newly Diagnosed Metastatic Stage IV Estrogen Receptor Positive Breast Cancer Start of enrollment: 2016 Sep 30
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 2 citationsOrgan-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer.Colt A Egelston, Weihua Guo, Diana L Simons, Jian Ye, Christian Avalos
Cancer Immunology Research. 2024-11-04 - 16 citationsTumor draining lymph nodes connected to cold triple-negative breast cancers are characterized by Th2-associated microenvironment.Weihua Guo, Jiayi Tan, Lei Wang, Colt A Egelston, Diana L Simons
Nature Communications. 2024-10-04 - 10 citationsUGT1A1*28 polymorphism and the risk of toxicity and disease progression in patients with breast cancer receiving sacituzumab govitecan.Megan H Wong, Veronica C Jones, Wai Yu, Linda D Bosserman, Sayeh M Lavasani
Cancer Medicine. 2024-08-01
Press Mentions
Online Tools May Boost Breast Cancer Patients' MoodAugust 30th, 2013
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
